Novo presented the post hoc look at its phase 3 trial at The Menopause Society Annual Meeting, focusing on results for women taking the combination shot.
Recap by typeshit. Full story at Menafn.
PHL17 shares findings that people on Ozempic and similar drugs are cutting alcohol spending at bars, restaurants and home.
Omer Raheem says he presented his team's work on GLP-1 therapies past weight loss at the ISSM Journals Webinar 2026.
The rundown covers CagriSema, retatrutide, MariTide, VK2735 and Roche's enicepatide, which the company says cut weight by 15.5% on average in a mid-stage trial.
Zhavoronkov links recorded ARDD 2026 sessions, among them Lilly's Kevin Duffin speaking on tirzepatide and aging clocks.
The BMJ reports that the person leading the UK government's national programme for trialling new obesity treatments has received nearly £80, with the full figure behind the link.
On his podcast, the NHS GP says studies show hunger hormones bounce back within four weeks, and he cites research on regaining about 60% of lost weight in a year.
Loading…